First Time Loading...

Kunlun Tech Co Ltd
SZSE:300418

Watchlist Manager
Kunlun Tech Co Ltd Logo
Kunlun Tech Co Ltd
SZSE:300418
Watchlist
Price: 39.98 CNY -2.44% Market Closed
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

19.9B
+1%
Assets
Growth Rates:
1 Year
+9%
3 Years
+56%
5 Years
+108%
7 Years
+234%
10 Years
-
5.6B
+2%
Liabilities
Growth Rates:
1 Year
-11%
3 Years
+51%
5 Years
+51%
7 Years
+94%
10 Years
-
14.3B
+1%
Equity
Growth Rates:
1 Year
+20%
3 Years
+58%
5 Years
+144%
7 Years
+365%
10 Years
-

Balance Sheet Decomposition
Kunlun Tech Co Ltd

19.9B
Assets
5.6B
Liabilities
19.9B
Assets
5.6B
Liabilities
Current Assets 4.3B
Cash & Short-Term Investments 3.3B
Receivables 784.7m
Other Current Assets 152.7m
Non-Current Assets 15.7B
Long-Term Investments 9B
PP&E 460.2m
Intangibles 5.9B
Other Non-Current Assets 341.6m
Current Liabilities 3B
Accounts Payable 1.4B
Accrued Liabilities 142.3m
Short-Term Debt 555m
Other Current Liabilities 961.4m
Non-Current Liabilities 2.6B
Long-Term Debt 94.8m
Other Non-Current Liabilities 2.5B

Balance Sheet
Kunlun Tech Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
660
704
1 048
1 076
2 024
1 516
2 805
3 245
1 545
883
Cash
2
0
0
0
0
0
0
0
1 545
883
Cash Equivalents
658
704
1 048
1 076
2 024
1 516
2 805
3 245
0
0
Short-Term Investments
0
0
0
0
0
0
60
355
833
1 501
Total Receivables
268
296
544
766
708
561
580
627
1 122
898
Accounts Receivables
230
254
289
580
410
363
375
523
595
785
Other Receivables
38
42
255
186
298
198
205
104
528
113
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
148
128
268
220
276
77
93
156
528
159
Total Current Assets
1 076
1 129
1 860
2 062
3 008
2 154
3 538
4 382
4 028
3 441
PP&E Net
26
31
25
26
23
22
15
81
184
210
PP&E Gross
26
31
25
26
23
22
15
0
184
210
Accumulated Depreciation
24
37
47
55
63
60
66
0
205
290
Intangible Assets
28
16
12
36
31
25
21
738
667
700
Goodwill
0
0
0
579
1 535
1 535
1 535
3 729
3 781
3 934
Note Receivable
0
0
0
0
0
0
0
1 435
944
1
Long-Term Investments
12
161
1 710
3 183
7 039
4 957
5 002
7 006
8 160
9 163
Other Long-Term Assets
108
132
281
420
425
136
146
169
134
111
Other Assets
0
0
0
579
1 535
1 535
1 535
3 729
3 781
3 934
Total Assets
1 250
N/A
1 468
+17%
3 888
+165%
6 306
+62%
12 061
+91%
8 829
-27%
10 257
+16%
17 541
+71%
17 899
+2%
17 561
-2%
Liabilities
Accounts Payable
144
222
327
350
242
490
2 292
1 588
2 543
1 607
Accrued Liabilities
36
54
54
82
116
158
94
118
185
194
Short-Term Debt
0
0
248
1 000
1 151
1 101
2 518
1 596
1 411
656
Current Portion of Long-Term Debt
0
0
0
0
0
728
0
35
61
61
Other Current Liabilities
216
177
554
950
546
539
449
459
271
244
Total Current Liabilities
396
453
1 183
2 383
2 054
3 016
5 354
3 796
4 471
2 762
Long-Term Debt
0
0
0
720
1 130
489
200
0
88
86
Deferred Income Tax
0
0
0
0
0
0
7
82
50
170
Minority Interest
0
0
0
29
153
161
0
3 142
2 910
1 845
Other Liabilities
0
3
25
22
15
8
6
20
0
0
Total Liabilities
396
N/A
456
+15%
1 208
+165%
3 154
+161%
3 352
+6%
3 674
+10%
5 566
+51%
7 041
+27%
7 518
+7%
4 863
-35%
Equity
Common Stock
210
210
1 127
1 127
1 152
1 151
1 148
1 173
1 198
1 186
Retained Earnings
485
646
981
1 395
2 272
3 177
3 808
8 971
9 403
10 478
Additional Paid In Capital
163
163
873
952
1 409
181
223
1 499
1 125
1 460
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
303
284
Treasury Stock
0
0
265
259
128
259
300
300
300
0
Other Equity
5
8
37
62
4 005
905
188
844
742
142
Total Equity
853
N/A
1 012
+19%
2 680
+165%
3 152
+18%
8 710
+176%
5 155
-41%
4 691
-9%
10 499
+124%
10 381
-1%
12 698
+22%
Total Liabilities & Equity
1 250
N/A
1 468
+17%
3 888
+165%
6 306
+62%
12 061
+91%
8 829
-27%
10 257
+16%
17 541
+71%
17 899
+2%
17 561
-2%
Shares Outstanding
Common Shares Outstanding
824
824
1 120
1 127
1 152
1 151
1 148
1 173
1 198
1 186

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.